CONTROLLED SUBSTANCE SCHEDULES                                                           S.B. 1131:

                                                                                                    SUMMARY OF BILL

                                                                                      REPORTED FROM COMMITTEE

 

 

 

 

 

 

 

 

 

Senate Bill 1131 (as reported without amendment)

Sponsor:  Senator Rick Jones

Committee:  Judiciary

 

CONTENT

 

The bill would amend Article 7 (Controlled Substances) of the Public Health Code to move from Schedule 3 to Schedule 2 a material containing limited quantities of a codeine-related narcotic and other ingredients.

 

Under the Code, a Schedule 1 controlled substance has high potential for abuse and has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision. A Schedule 2 controlled substance has high potential for abuse; has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and the abuse of the substance may lead to severe psychic or physical dependence. A Schedule 3 substance has a potential for abuse less than the substances listed in Schedules 1 and 2, and has currently accepted medical use in treatment in the United States; and abuse of the substance may lead to moderate or low physical dependence or high psychological dependence.

 

The list of Schedule 3 controlled substances includes any material, compound, mixture, or preparation containing any of the following:

 

 --    Not more than 300 milligrams of dihydrocodeinone, or any of its salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.

 --    Not more than 300 milligrams of dihydrocodeinone, or any of its salts, per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts.

 --    Not more than 1.8 grams of dihydrocodeine, or any of its salts, per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts.

 

Under the bill, the substances described above instead would be listed as Schedule 2 controlled substances.

 

MCL 333.7214 & 333.7216                                         Legislative Analyst:  Patrick Affholter

 

FISCAL IMPACT

 

Changing the categorization of certain substances from Schedule 3 to Schedule 2 would change the felony and misdemeanor penalties associated with violations. In calendar year 2013, for the court dispositions associated with these controlled substances, there were approximately 200 people whose felony convictions resulted in a prison sentence. The data do not indicate whether those convictions were the result of the manufacture, possession, or use of the controlled substances listed in the bill. For felony sentence convictions, in the short term, the marginal cost to State government would be approximately $4,100 per


additional prisoner per year. Over the long term, the marginal cost to State government would be approximately $31,100 per additional prisoner per year. Since the more severe felony and misdemeanor offense penalties for schedule 2 violations would not increase the number of cases, costs to local courts and law enforcement should be unchanged. An increase in the fine revenue collected could increase revenue for public libraries.

 

Date Completed:  11-13-14                                                  Fiscal Analyst:  John Maxwell

This analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official statement of legislative intent.